Therapeutic area

Immune system disorders – page 135

1 638 clinical trials
557 recruiting
289 conditions
28 countries

Clinical trials in Immune system disorders

1 638 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

1 638 clinical trials

Cholangitis sclerosing

Not recruiting

Investigational

Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

Investigational

Austria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Norucholic Acid
Sponsor:Dr. Falk Pharma GmbH

Contact Research Centre

Transplant rejection

Not recruiting

Registered drug

Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

InvestigationalNo placebo

Hungary

Participants:0–17 years
Substances:Nemolizumab
Sponsor:Galderma S.A.

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Human Normal Immunoglobulin for New Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:Region Midtjylland

Contact Research Centre

Mucous membrane pemphigoid

Not recruiting

Registered drug

Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Glucose
Sponsor:Centre Hospitalier Universitaire Rouen

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Abacavir Sulfate
Sponsor:Stichting Radboud universitair medisch centrum

Contact Research Centre

Systemic scleroderma

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Nintedanib
Sponsor:Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher

Contact Research Centre

Conjunctivitis allergic+1

Not recruiting

Registered drug

Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Registered drug

Germany

Participants:0–17 years · 18–64 years
Substances:Bilastine
Sponsor:Inmunotek S.L.

Contact Research Centre

Primary biliary cholangitis

Not recruiting

Investigational

Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Golexanolone
Sponsor:Umecrine Cognition AB

Contact Research Centre

Acute respiratory distress syndrome+3

Not recruiting

Registered drugNo placebo

Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Imlifidase
Sponsor:Charite Universitaetsmedizin Berlin KöR

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug

Austria

Participants:18–64 years
Substances:Colestyramine
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Cenerimod
Sponsor:Viatris Innovation GmbH

Contact Research Centre

Substances studied in this area

The therapies tested most often in Immune system disorders trials.

Sodium Chloride61 clinical trials Rituximab50 clinical trials Prednisone47 clinical trials Adalimumab39 clinical trials Emtricitabine39 clinical trials Tocilizumab38 clinical trials Tenofovir Alafenamide37 clinical trials Methotrexate36 clinical trials Prednisolone35 clinical trials

Immune system disorders – page 135

Conditions in this area

Clinical trials in Immune system disorders

1 638 clinical trials

Cholangitis sclerosing

Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

Transplant rejection

Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Dermatitis atopic

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

Chronic inflammatory demyelinating polyradiculoneuropathy

Study Comparing Subcutaneous and Intravenous Human Normal Immunoglobulin for New Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Mucous membrane pemphigoid

Study on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid

HIV infection

Study on the Effects of Abacavir Sulfate and Etravirine in Pregnant Women with HIV

Systemic scleroderma

Study on the Effectiveness of Nintedanib and Tocilizumab for Patients with Systemic Sclerosis and Interstitial Lung Disease

Conjunctivitis allergic+1

Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Primary biliary cholangitis

Study on Golexanolone for Patients with Primary Biliary Cholangitis Experiencing Fatigue and Cognitive Dysfunction

Acute respiratory distress syndrome+3

Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

Multiple sclerosis

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Systemic lupus erythematosus

Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.